Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database

Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database

Thumbnail Image
Download
Name

134_2018_5208_ReferencePDF.pdf

Size

555.68 KB

Format

Adobe PDF

Checksum (MD5)

80416e025c91c3eab817972e092e5af5

Download all files submitted through automated deposit
art_1926563511509193155.zip (534.12 KB)
Author(s)
Feng, Mengling
•
McSparron, Jakob I
•
Kien, Dang T
•
Stone, David J
•
Roberts, David H
•
Schwartzstein, Richard M
•
Vieillard-Baron, Antoine
•
Celi, Leo A
Date Issued
May 28, 2018
Publisher
Springer Berlin Heidelberg
Version
Author's final manuscript
Abstract
Abstract Purpose While the use of transthoracic echocardiography (TTE) in the ICU is rapidly expanding, the contribution of TTE to altering patient outcomes among ICU patients with sepsis has not been examined. This study was designed to examine the association of TTE with 28-day mortality specifically in that population. Methods and results The MIMIC-III database was employed to identify patients with sepsis who had and had not received TTE. The statistical approaches utilized included multivariate regression, propensity score analysis, doubly robust estimation, the gradient boosted model, and an inverse probability-weighting model to ensure the robustness of our findings. Significant benefit in terms of 28-day mortality was observed among the TTE patients compared to the control (no TTE) group (odds ratio = 0.78, 95% CI 0.68–0.90, p < 0.001). The amount of fluid administered (2.5 vs. 2.1 L on day 1, p < 0.001), use of dobutamine (2% vs. 1%, p = 0.007), and the maximum dose of norepinephrine (1.4 vs. 1 mg/min, p = 0.001) were significantly higher for the TTE patients. Importantly, the TTE patients were weaned off vasopressors more quickly than those in the no TTE group (vasopressor-free days on day 28 of 21 vs. 19, p = 0.004). Conclusion In a general population of critically ill patients with sepsis, use of TTE is associated with an improvement in 28-day mortality.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
https://hdl.handle.net/1721.1/131429
DOI of Published Version
https://doi.org/10.1007/s00134-018-5208-7
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.